Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Carcinogenesis

Abstract LB-69: Role of HDAC1 in epigenetic repression of E-cadherin after transient Epstein Barr virus infection

Krista J. Queen and Rona S. Scott
Krista J. Queen
1LSU Health, Shreveport, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rona S. Scott
1LSU Health, Shreveport, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2012-LB-69 Published April 2012
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL

Abstract

Epstein-Barr virus (EBV) is a gammaherpesvirus associated with a variety of lymphoid and epithelial tumors. Although EBV is a known tumor virus, incomplete association of EBV with any given tumor type has confounded its role in tumorigenesis. For example, only 15% of gastric carcinomas are EBV-positive compared to virtually all undifferentiated nasopharyngeal carcinomas. Upon entry into a cell, the viral genome is chromatinized and EBV rapidly shuts off its viral gene expression program via methylation of its viral promoters in an attempt to evade the host immune response. A similar restricted pattern of viral gene expression is present in EBV-positive tumors. We hypothesize that EBV infection of tumor cells results in virus-induced epigenetic alterations to host genes that remain after loss of the virus and may provide a selective advantage to the tumor cell. To identify virally induced epigenetic alterations, we established a transient model of infection to model the effects of viral redundancy and loss in carcinogenesis. Carcinoma cell lines were infected with recombinant EBV, passaged with selective pressure, and allowed to lose viral genomes by withdrawal of selection. Transient EBV infection of lung carcinoma cells resulted in numerous gene expression changes relative to uninfected controls suggestive of cellular epigenetic reprogramming. Two such gene expression changes, PYCARD and E-cadherin were found to be due to DNA methylation and loss of histone acetylation, respectively. To understand the mechanism behind loss of histone acetylation at the E-cadherin locus following transient EBV infection, we examined the role of histone deacetylases (HDACs) in mediating the epigenetic repression. We observed an increase in total HDAC activity in our transiently infected, EBV-negative clones. Through the use of specific inhibitors, we noted class I HDACs, specifically HDAC1, was involved in the repression of E-cadherin in transiently infected clones. EBV-modulation of HDAC1 activity may lead to host epigenetic alterations that are retained after loss of the virus. Future experiments are aimed at determining the viral and cellular players responsible for the epigenetic alterations that are seen in transiently infected, EBV-negative clones. These results suggest that EBV alters cellular gene expression in a heritable fashion in formerly infected cells, while its own contribution to the oncogenic process is masked.

Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-69. doi:1538-7445.AM2012-LB-69

  • ©2012 American Association for Cancer Research
Back to top
Cancer Research: 72 (8 Supplement)
April 2012
Volume 72, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract LB-69: Role of HDAC1 in epigenetic repression of E-cadherin after transient Epstein Barr virus infection
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract LB-69: Role of HDAC1 in epigenetic repression of E-cadherin after transient Epstein Barr virus infection
Krista J. Queen and Rona S. Scott
Cancer Res April 15 2012 (72) (8 Supplement) LB-69; DOI: 10.1158/1538-7445.AM2012-LB-69

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract LB-69: Role of HDAC1 in epigenetic repression of E-cadherin after transient Epstein Barr virus infection
Krista J. Queen and Rona S. Scott
Cancer Res April 15 2012 (72) (8 Supplement) LB-69; DOI: 10.1158/1538-7445.AM2012-LB-69
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Carcinogenesis

  • Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis
  • Abstract LB-090: Estrogen metabolism within the human lung: impact of tumorigenesis, tobacco smoke, gender and race
  • Abstract LB-091: Characterization of molecular changes occurring during long-term treatment of human bronchial epithelial cells with cigarette smoke total particulate matter
Show more 3

Poster Presentations - Late-Breaking Abstracts

  • Abstract LB-304: Discovery of chemical probe CCT251236: An orally bioavailable efficacious pirin ligand from an HSF1 phenotypic screen
  • Abstract LB-302: Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma
  • Abstract LB-246: Detection of circulating tumor DNA in early stage cancers
Show more 3

Late-Breaking Poster Presentations - Carcinogenesis: Chemical, Viral, and Radiation

  • Abstract LB-66: Oncogenic properties of tax protein from human T cell leukemia virus type 2
  • Abstract LB-63: (S)-N′-nitrosonornicotine, a constituent of smokeless tobacco, is a potent oral tumorigen in rats
  • Abstract LB-67: COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma associated herpes virus (KSHV) oncoprotein-v-FLIP
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement